Press Releases

June 14, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES FOR VANCOUVER TODAY JUNE 14, 2021

June 03, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES FOR MONTREAL AND EAST OF CANADA TODAY JUNE 3RD, 2021

May 26, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES IN BOSTON (USA) TODAY MAY 26, 2021

May 13, 2021 DEVONIAN HEATH GROUP INC. TO PRESENT AT THE CANADA INDIA HEALTHCARE SUMMIT 2021

May 11, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON THURSDAY, MAY 13, 2021

April 14, 2021 DEVONIAN HEALTH GROUP INC. RETAINS RENMARK FINANCIAL COMMUNICATIONS INC. TO PROVIDE INVESTOR RELATIONS SERVICES

March 30, 2021 Devonian Health Group Announces Notice of Allowance for a US Patent Application Covering use of Thykamine™ for the treatment of Cardiovascular Diseases

March 25, 2021 Devonian Health Group provides more details on Previously Announced Positive Topline Results from Phase 2 Clinical trial of Thykamine™ in Adult Population with Mild-to-Moderate Atopic Dermatitis and the Grant of Stock Options

March 05, 2021 DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO DEBENTURE HOLDERS

February 18, 2021 Devonian Health Group Announces Positive Topline Results from Phase 2 Clinical trial of Thykamine™ in Adult Patients with Mild-to-Moderate Atopic Dermatitis

January 28, 2021 Devonian Health Group Announces voting results of the Annual General and Special Meeting

January 22, 2021 DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO A DEBENTURE HOLDER